CA2392154A1 - Volume meter testing device - Google Patents
Volume meter testing device Download PDFInfo
- Publication number
- CA2392154A1 CA2392154A1 CA002392154A CA2392154A CA2392154A1 CA 2392154 A1 CA2392154 A1 CA 2392154A1 CA 002392154 A CA002392154 A CA 002392154A CA 2392154 A CA2392154 A CA 2392154A CA 2392154 A1 CA2392154 A1 CA 2392154A1
- Authority
- CA
- Canada
- Prior art keywords
- area
- fluid
- test device
- read
- pickup
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/026—Fluid interfacing between devices or objects, e.g. connectors, inlet details
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0663—Whole sensors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0681—Filter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/069—Absorbents; Gels to retain a fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0825—Test strips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
Abstract
A test device adapted to test a concentration of an analyte in a fluid has a pickup area having a first volume for receiving the fluid. In fluid communication with the pickup area is a read area having a second volume, which is less than the first volume. Since the second volume is less than the first volume, fluid from the pickup area will flow into the read area only after the pickup area is full. The read area also contains a reagent that is adapted to indi-cate the concentration of the analyte in the fluid.
Description
v VOLUME METER TESTING DEVICE
FIELD OF THE INVENTION
The present invention relates generally to blood monitoring devices and, more particularly, to a volume metering test device for obtaining a sample of blood.
BACKGROUND OF THE INVENTION
It is often necessary to quickly obtain a sample of blood and perform an analy sis of the blood sample. One example of a need for quickly obtaining a sample of blood is in connection with a blood glucose monitoring system where a user must fre quently use the system to monitor the user's blood glucose level.
Those who have irregular blood glucose concentration levels are medically re-quired to self monitor their blood glucose concentration level. An irregular blood glucose level can be brought on by a variety of reasons including illness, such as dia-betes. The purpose of monitoring the blood glucose concentration level is to deter-mine the blood glucose concentration level and then to take corrective action, based upon whether the level is too high or too low, to bring the level back within a normal range. The failure to take corrective action can have serious implications.
When blood glucose levels drop too low, a condition known as hypoglycemia, a person can become nervous, shaky, and confused. That person's judgment may become impaired and that person may eventually pass out. A person can also become very ill if their blood glucose level becomes too high, a condition known as hyperglycemia. Both conditions, hypoglycemia and hyperglycemia, are potentially life-threatening emer-gencies.
FIELD OF THE INVENTION
The present invention relates generally to blood monitoring devices and, more particularly, to a volume metering test device for obtaining a sample of blood.
BACKGROUND OF THE INVENTION
It is often necessary to quickly obtain a sample of blood and perform an analy sis of the blood sample. One example of a need for quickly obtaining a sample of blood is in connection with a blood glucose monitoring system where a user must fre quently use the system to monitor the user's blood glucose level.
Those who have irregular blood glucose concentration levels are medically re-quired to self monitor their blood glucose concentration level. An irregular blood glucose level can be brought on by a variety of reasons including illness, such as dia-betes. The purpose of monitoring the blood glucose concentration level is to deter-mine the blood glucose concentration level and then to take corrective action, based upon whether the level is too high or too low, to bring the level back within a normal range. The failure to take corrective action can have serious implications.
When blood glucose levels drop too low, a condition known as hypoglycemia, a person can become nervous, shaky, and confused. That person's judgment may become impaired and that person may eventually pass out. A person can also become very ill if their blood glucose level becomes too high, a condition known as hyperglycemia. Both conditions, hypoglycemia and hyperglycemia, are potentially life-threatening emer-gencies.
2 5 One method of monitoring a person's blood glucose level is with a portable, hand-held blood glucose testing device. A prior art blood glucose testing device 100 is illustrated in FIG. 1. The portable nature of these devices 100 enables the users to conveniently test their blood glucose levels wherever the user may be. The glucose testing device contains a test sensor 102 to harvest the blood for analysis.
The device 3 0 100 contains a switch 104 to activate the device 100 and a display 106 to display the blood glucose analysis results. In order to check the blood glucose level, a drop of blood is obtained from the fingertip using a lancing device. A prior art lancing device 120 is illustrated in FIG. 2. The lancing device 120 contains a needle lance 122 to puncture the skin. Some lancing devices implement a vacuum to facilitate drawing blood. Once the requisite amount of blood is produced on the fingertip, the blood is harvested using the test sensor 102. The test sensor 102, which is inserted into a test-s ing unit 100, is brought into contact with the blood drop. The test sensor 102 draws the blood to the inside of the test unit 100, which then determines the concentration of glucose in the blood. Once the results of the test are displayed on the display 106 of the test unit 100, the test sensor 102 is discarded. Each new test requires a new test sensor 102.
1 o One problem associated with some conventional test sensors is that the proper amount of blood may not be obtained. The test sensor used needs a minimum amount of blood to provide accurate results. If the proper amount of blood is not received, inaccurate results may be generated.
Another problem associated with some conventional test sensors is that the ~ 5 user cannot ensure that the proper amount of blood has been obtained. The user ap-plies the blood directly onto a read area and then obtains a reading from the device. If an unusual reading is given, the user may surmise that the unusual reading was caused by an improper amount of blood being obtained. The user may then try again.
There is no way for the user to know, however, if that is the true reason for the unusual re 2 0 salt.
Another problem associated with some conventional test sensors is the pres-ence of air gaps in the blood sample that is being read. Air gaps in the blood sample can also cause inaccurate readings, requiring the user to retest.
Another problem associated with some conventional test sensors is that the 2 5 user's blood physically contacts the elements within the testing unit.
Cross contamination can be a problem if the monitoring device is used by more than one user, such as in a doctor's office or other clinical setting.
SUMMARY OF THE INVENTION
3 o A test sensor adapted to test a concentration of an analyte in a fluid has a pickup area having a first volume for receiving the fluid. In fluid communication with the pickup area is a read area having a second volume, which is less than the first vol-ume. Since the second volume is less than the first volume, fluid from the pickup area will flow into the read area only after the pickup area is full. The read area also con-tains a reagent that is adapted to indicate the concentration of the analyte in the fluid.
BRIEF DESCRIPTION OF THE DRAWINGS
The foregoing and other advantages of the invention will become apparent upon reading the following detailed description and upon reference to the drawings.
FIG. 1 is a top view of a prior art blood glucose testing device.
FIG. 2 is a perspective view of a prior art lance.
1 o FIG. 3 is a side view of a test device according to one embodiment of the pres-ent invention.
FIG. 4 is a bottom view of the test device illustrated in FIG. 3.
FIG. 5 is a top view of the test device illustrated in FIG. 3.
FIG. 6 is a perspective view of the test device illustrated in FIG. 3, with a por-tion removed to better illustrate a read portion of the test device.
FIG. 7 is a top view of another embodiment of the test device.
FIG. 8 is a side view of the test device illustrated in FIG. 7, cut along line B-B.
While the invention is susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings 2 0 and will be described in detail herein. It should be understood, however, that the in-vention is not intended to be limited to the particular forms disclosed.
Rather, the in-vention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
FIG. 3 depicts a schematic view of the side of a test device 200 according to one embodiment of the present invention. The test device 200 includes a format 205, a pickup area 210, a transfer area 220, a read area 230, a vent area 240, and a cover 250. The test device 200 is designed to collect a fluid, for example, blood, so the fluid 3 0 may be tested for the concentration of a particular analyte, such as glucose. In de-scribing the details of the operation of the test device 200, the fluid described will be blood pricked from a finger and the analyte will be glucose. It is understood that the embodiment may also be used for other fluids and analytes and that these only serve as examples.
After a finger is pricked for blood, the pickup area 210 is placed in contact with the wound. Using capillary action, described below, the blood moves into the pickup area 210. The blood flows from the pickup area into the transfer area 220 and then into the read area 230. The cover 250 develops the capillary gap in the read area 230 and also retains the blood within the test device, protecting the test unit from contamination.
The read area 230 includes a reagent which is designed to react with the glu t o cose to produce a colormetric or electrochemical response. The test unit 100 then measures the colormetric or electrochemical response. The reagent used in the read area 230 depends on the type of analyte desired.
In one embodiment, the test device 200 can be used in conjunction with a photometric test unit, which measures the colormetric reaction. In photometric test ing, the reagent used causes a change in color in the read area. The photometric test unit then reads the amount of color change. Photometric testing is described in more detail in commonly-owned U.S. Patent No. 5,611,999 entitled "Diffuse Reflectance Readhead" which is incorporated herein by reference in its entirety. It is also contem plated that other methods of testing the concentration of glucose in blood may be 2 0 utilized.
In another embodiment of the test device 200, an electrochemical test unit is employed. The read area 230 includes a pair of electrodes (not shown). In electro-chemical analysis, the change in current across the electrodes caused by the reaction of the glucose and the reagent creates an oxidation current at the electrodes which is 2 5 directly proportional to the user's blood glucose concentration. The current can be measured by an electrochemical test unit coupled to a pair of terminals (not shown) corresponding to the electrodes. The electrochemical test unit can then communicate to the user the blood glucose concentration. An example of an electrochemical test system is described in detail by commonly-owned U.S. Patent No. 5,723,284 entitled 3 0 "Control Solution And Method For Testing The Performance Of An Electrochemical Device For Determining The Concentration Of An Analyte In Blood" which is incor-porated herein by reference in its entirety.
Referring now to FIGS. 3 through 5, a side view, a bottom view, and a top view are shown. Through capillary action, the blood flows into the test device 200 at the pickup area 210. The pickup area 210 has a first sidewall 260 and a second side-wall 270, which create a capillary gap 280 having a thickness t,. The capillary gap 280, thus, facilitates the capillary action. Proceeding the pickup area 210 is a nib 215.
The nib 215 does not have either a floor or a ceiling. Elimination of a floor and a ceiling at the pickup area 210 insures that the pickup area 210 is not closed when the nib 215 is in direct contact with the wound on the finger. Closing the pickup area 210 entirely could create a vacuum which potentially destroys the capillary action. The pickup area 210 has a volume v,, which is larger than the required volume needed to accurately test the blood. The volume v, of the pickup area 210 is designed to ensure that at least a requisite amount of blood is obtained with each test. Creating a large pickup area 210 decreases the likelihood that a user will need to retest due to lack of a sufficient volume of blood.
The transfer area 220 is in fluid communication with the pickup area 210 and the read area 230. The transfer area 220 is designed to transfer the blood from the pickup area 210 to the read area 230. A second capillary gap 290 having a thickness of t2 is created in the transfer area by a first and second sidewall 300, 310.
The thick-ness t2 of the second capillary gap 290 is less than the thickness of t, of the first capil-2 0 lary gap 280. The blood will not flow into an area with a smaller capillary gap until the area with the larger capillary gap is completely filled. In other words, an area with a smaller capillary gap cannot exert enough force to draw blood from an area having a larger capillary gap. Once the pickup area 210 is full of the blood, then the blood flows into the area with the smaller capillary gap. The transfer area 220 has a volume 2 5 v2 which is less than the volume v, of the pickup area 210. Since the volume v, of the pickup area 210 is larger than the volume v2 of the transfer area and the pickup area 210 must be filled prior to the transfer area 220 drawing the blood, the testing device 200 ensures that at least a requisite amount of blood is obtained from the user.
After filling the transfer area 220 with blood, the blood next flows into the 3 0 read area 230 by way of capillary action. The read area 230 is an island surrounded by the vent area 240. As blood moves into the read area 230, the air in the read area 230 escapes into the vent area 240. This ensures that the blood continues to flow into the read area 230 and also aids in the prevention of air pockets forming in the read area 230 during the testing process.
The read area 230 comprises a floor 320 and a ceiling 330. The floor 320 is a top side of the cover 250. The ceiling 330 is a portion of the format, illustrated in FIG. 3. The read area 230 does not include any sidewalls. The inventor has found that air can become trapped along the sidewalls of the read area 230. The presence of air in the read area 230 increases the risk of obtaining an inaccurate result.
By elimi-nating the sidewalls, air cannot become entrapped in the read area 230, as it all flows out into the vent area 240, and the possibility of erroneous test results is decreased.
1 o To ensure a complete filling of the read area 230, the floor 320 and ceiling 330 create a capillary gap 340 having a thickness t3 (FIG. 6) that is less than the thickness t2 of the capillary gap 290 of the transfer area 220. Therefore, blood will not move into the read area 230 until the transfer area 220 is completely filled. The read area 230 has a volume v3 which is less than the volume v2 of the transfer area. Thus, once the transfer area 220 is completely filled, there is enough blood drawn into the testing de-vice 200 to insure a proper reading. Since the read area 230 will not begin to draw the blood from the transfer area 220 until the transfer area 220 is full, a user may be as sured that enough blood to provide an accurate reading has been obtained. The capil lary gap 340 is maintained at a thickness t3 because the format 205 (the ceiling 330) is 2 0 made of a plastic film that retains its shape.
In one embodiment, the volume v3 of the read area is from about 70 to about 80 percent of the volume v, of the pickup area. In another embodiment, the pickup area 210 has a volume of from about 5.0 to about 5.5 microliters and the read area 230 has a volume from about 3.5 to about 4.0 microliters. The volume v2 of the transfer 2 5 area 220 may be anywhere between the volume v, of the pickup area 210 and the vol-ume v3 of the read area 230.
In one embodiment, the thickness t, of the first capillary gap 280 is in the range of about 0.025 to about 0.030 inch. The thickness t2 of the second capillary gap 290 is in the range of about 0.015 to about 0.020 inch. The thickness t2 of the second 3 o capillary gap 290, however, is less than the thickness t, of the first capillary gap 280.
The thickness t3 of the third capillary gap 340 is in the range of about 0.008 to about 0.0012 inch. The thickness t3 of the third capillary gap 340 must remain less than the thicknesses t, and t2 of the first and second capillary gaps 280, 290.
The operation of the device will now be described. The user moves the pickup area 210 into contact with a drop of blood on the user's fingertip. The pickup area 210 then fills with blood from the user's fingertip. Once the pickup area 210 is full, the transfer area 220 begins to fill with the blood. As discussed above, once the trans-fer area 220 begins to fill with blood, the user may then remove the testing device 200 from the user's fingertip. Since the transfer area 220 does not begin to fill with blood until after the pickup area is filled, and the pickup area has a volume v, greater than l0 the requisite volume needed for an accurate reading, the user can be assured that enough blood has been drawn.
Once the blood has filled the transfer area 220, the blood then begins to fill the read area 230. After the read area 230 is filled with blood, the sensor then reads the resulting change and indicates the glucose concentration to the user.
Turning now to FIGS. 7 and 8, an alternate embodiment of the test device 200 will be described. FIG. 7 is a top view of the test device, and FIG. 8 is a perspective view of the test device of FIG. 7, cut along line 7-7. Features that are the same as the previous embodiment will be numbered the same in this embodiment. In this em-bodiment, the read area 230 includes a capillary gap 820 created by supports 830, a 2 o filter 810, and a reagent impregnated paper 840. The filter 830 and reagent impreg-nated paper 840 are below the capillary gap 820. In this configuration, the blood needs to pass through the filter 810 before the reagent reacts with the blood.
It is also important to have the blood sample spread uniformly across the surface of the filter 810 prior to penetrating the filter 810 and reaching the top surface of the reagent im-2 5 pregnated paper 840, penetrating the reagent impregnated paper 840 and reacting with the reagent.
The capillary gap 820 above the filter 810 is produced by supports in the test device 200 and is arranged in such a pattern to promote spreading across the top sur-face of the filter 810. Thus, a uniform color change can be created along the read sur-3 o face of the reagent impregnated paper 840, allowing for an accurate reading by a photometric test unit.
The capillary gap distance t4 is less than the thickness t2 of the capillary gap 290 of the transfer area 220. Thus, the flow of blood acts the same in this embodi-ment.
While the present invention has been described with reference to one or more particular embodiments, those skilled in the art will recognize that many changes may be made thereto without departing from the spirit and scope of the present invention.
Each of these embodiments and obvious variations thereof is contemplated as falling within the spirit and scope of the claimed invention, which is set forth in the following claims.
The device 3 0 100 contains a switch 104 to activate the device 100 and a display 106 to display the blood glucose analysis results. In order to check the blood glucose level, a drop of blood is obtained from the fingertip using a lancing device. A prior art lancing device 120 is illustrated in FIG. 2. The lancing device 120 contains a needle lance 122 to puncture the skin. Some lancing devices implement a vacuum to facilitate drawing blood. Once the requisite amount of blood is produced on the fingertip, the blood is harvested using the test sensor 102. The test sensor 102, which is inserted into a test-s ing unit 100, is brought into contact with the blood drop. The test sensor 102 draws the blood to the inside of the test unit 100, which then determines the concentration of glucose in the blood. Once the results of the test are displayed on the display 106 of the test unit 100, the test sensor 102 is discarded. Each new test requires a new test sensor 102.
1 o One problem associated with some conventional test sensors is that the proper amount of blood may not be obtained. The test sensor used needs a minimum amount of blood to provide accurate results. If the proper amount of blood is not received, inaccurate results may be generated.
Another problem associated with some conventional test sensors is that the ~ 5 user cannot ensure that the proper amount of blood has been obtained. The user ap-plies the blood directly onto a read area and then obtains a reading from the device. If an unusual reading is given, the user may surmise that the unusual reading was caused by an improper amount of blood being obtained. The user may then try again.
There is no way for the user to know, however, if that is the true reason for the unusual re 2 0 salt.
Another problem associated with some conventional test sensors is the pres-ence of air gaps in the blood sample that is being read. Air gaps in the blood sample can also cause inaccurate readings, requiring the user to retest.
Another problem associated with some conventional test sensors is that the 2 5 user's blood physically contacts the elements within the testing unit.
Cross contamination can be a problem if the monitoring device is used by more than one user, such as in a doctor's office or other clinical setting.
SUMMARY OF THE INVENTION
3 o A test sensor adapted to test a concentration of an analyte in a fluid has a pickup area having a first volume for receiving the fluid. In fluid communication with the pickup area is a read area having a second volume, which is less than the first vol-ume. Since the second volume is less than the first volume, fluid from the pickup area will flow into the read area only after the pickup area is full. The read area also con-tains a reagent that is adapted to indicate the concentration of the analyte in the fluid.
BRIEF DESCRIPTION OF THE DRAWINGS
The foregoing and other advantages of the invention will become apparent upon reading the following detailed description and upon reference to the drawings.
FIG. 1 is a top view of a prior art blood glucose testing device.
FIG. 2 is a perspective view of a prior art lance.
1 o FIG. 3 is a side view of a test device according to one embodiment of the pres-ent invention.
FIG. 4 is a bottom view of the test device illustrated in FIG. 3.
FIG. 5 is a top view of the test device illustrated in FIG. 3.
FIG. 6 is a perspective view of the test device illustrated in FIG. 3, with a por-tion removed to better illustrate a read portion of the test device.
FIG. 7 is a top view of another embodiment of the test device.
FIG. 8 is a side view of the test device illustrated in FIG. 7, cut along line B-B.
While the invention is susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings 2 0 and will be described in detail herein. It should be understood, however, that the in-vention is not intended to be limited to the particular forms disclosed.
Rather, the in-vention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
FIG. 3 depicts a schematic view of the side of a test device 200 according to one embodiment of the present invention. The test device 200 includes a format 205, a pickup area 210, a transfer area 220, a read area 230, a vent area 240, and a cover 250. The test device 200 is designed to collect a fluid, for example, blood, so the fluid 3 0 may be tested for the concentration of a particular analyte, such as glucose. In de-scribing the details of the operation of the test device 200, the fluid described will be blood pricked from a finger and the analyte will be glucose. It is understood that the embodiment may also be used for other fluids and analytes and that these only serve as examples.
After a finger is pricked for blood, the pickup area 210 is placed in contact with the wound. Using capillary action, described below, the blood moves into the pickup area 210. The blood flows from the pickup area into the transfer area 220 and then into the read area 230. The cover 250 develops the capillary gap in the read area 230 and also retains the blood within the test device, protecting the test unit from contamination.
The read area 230 includes a reagent which is designed to react with the glu t o cose to produce a colormetric or electrochemical response. The test unit 100 then measures the colormetric or electrochemical response. The reagent used in the read area 230 depends on the type of analyte desired.
In one embodiment, the test device 200 can be used in conjunction with a photometric test unit, which measures the colormetric reaction. In photometric test ing, the reagent used causes a change in color in the read area. The photometric test unit then reads the amount of color change. Photometric testing is described in more detail in commonly-owned U.S. Patent No. 5,611,999 entitled "Diffuse Reflectance Readhead" which is incorporated herein by reference in its entirety. It is also contem plated that other methods of testing the concentration of glucose in blood may be 2 0 utilized.
In another embodiment of the test device 200, an electrochemical test unit is employed. The read area 230 includes a pair of electrodes (not shown). In electro-chemical analysis, the change in current across the electrodes caused by the reaction of the glucose and the reagent creates an oxidation current at the electrodes which is 2 5 directly proportional to the user's blood glucose concentration. The current can be measured by an electrochemical test unit coupled to a pair of terminals (not shown) corresponding to the electrodes. The electrochemical test unit can then communicate to the user the blood glucose concentration. An example of an electrochemical test system is described in detail by commonly-owned U.S. Patent No. 5,723,284 entitled 3 0 "Control Solution And Method For Testing The Performance Of An Electrochemical Device For Determining The Concentration Of An Analyte In Blood" which is incor-porated herein by reference in its entirety.
Referring now to FIGS. 3 through 5, a side view, a bottom view, and a top view are shown. Through capillary action, the blood flows into the test device 200 at the pickup area 210. The pickup area 210 has a first sidewall 260 and a second side-wall 270, which create a capillary gap 280 having a thickness t,. The capillary gap 280, thus, facilitates the capillary action. Proceeding the pickup area 210 is a nib 215.
The nib 215 does not have either a floor or a ceiling. Elimination of a floor and a ceiling at the pickup area 210 insures that the pickup area 210 is not closed when the nib 215 is in direct contact with the wound on the finger. Closing the pickup area 210 entirely could create a vacuum which potentially destroys the capillary action. The pickup area 210 has a volume v,, which is larger than the required volume needed to accurately test the blood. The volume v, of the pickup area 210 is designed to ensure that at least a requisite amount of blood is obtained with each test. Creating a large pickup area 210 decreases the likelihood that a user will need to retest due to lack of a sufficient volume of blood.
The transfer area 220 is in fluid communication with the pickup area 210 and the read area 230. The transfer area 220 is designed to transfer the blood from the pickup area 210 to the read area 230. A second capillary gap 290 having a thickness of t2 is created in the transfer area by a first and second sidewall 300, 310.
The thick-ness t2 of the second capillary gap 290 is less than the thickness of t, of the first capil-2 0 lary gap 280. The blood will not flow into an area with a smaller capillary gap until the area with the larger capillary gap is completely filled. In other words, an area with a smaller capillary gap cannot exert enough force to draw blood from an area having a larger capillary gap. Once the pickup area 210 is full of the blood, then the blood flows into the area with the smaller capillary gap. The transfer area 220 has a volume 2 5 v2 which is less than the volume v, of the pickup area 210. Since the volume v, of the pickup area 210 is larger than the volume v2 of the transfer area and the pickup area 210 must be filled prior to the transfer area 220 drawing the blood, the testing device 200 ensures that at least a requisite amount of blood is obtained from the user.
After filling the transfer area 220 with blood, the blood next flows into the 3 0 read area 230 by way of capillary action. The read area 230 is an island surrounded by the vent area 240. As blood moves into the read area 230, the air in the read area 230 escapes into the vent area 240. This ensures that the blood continues to flow into the read area 230 and also aids in the prevention of air pockets forming in the read area 230 during the testing process.
The read area 230 comprises a floor 320 and a ceiling 330. The floor 320 is a top side of the cover 250. The ceiling 330 is a portion of the format, illustrated in FIG. 3. The read area 230 does not include any sidewalls. The inventor has found that air can become trapped along the sidewalls of the read area 230. The presence of air in the read area 230 increases the risk of obtaining an inaccurate result.
By elimi-nating the sidewalls, air cannot become entrapped in the read area 230, as it all flows out into the vent area 240, and the possibility of erroneous test results is decreased.
1 o To ensure a complete filling of the read area 230, the floor 320 and ceiling 330 create a capillary gap 340 having a thickness t3 (FIG. 6) that is less than the thickness t2 of the capillary gap 290 of the transfer area 220. Therefore, blood will not move into the read area 230 until the transfer area 220 is completely filled. The read area 230 has a volume v3 which is less than the volume v2 of the transfer area. Thus, once the transfer area 220 is completely filled, there is enough blood drawn into the testing de-vice 200 to insure a proper reading. Since the read area 230 will not begin to draw the blood from the transfer area 220 until the transfer area 220 is full, a user may be as sured that enough blood to provide an accurate reading has been obtained. The capil lary gap 340 is maintained at a thickness t3 because the format 205 (the ceiling 330) is 2 0 made of a plastic film that retains its shape.
In one embodiment, the volume v3 of the read area is from about 70 to about 80 percent of the volume v, of the pickup area. In another embodiment, the pickup area 210 has a volume of from about 5.0 to about 5.5 microliters and the read area 230 has a volume from about 3.5 to about 4.0 microliters. The volume v2 of the transfer 2 5 area 220 may be anywhere between the volume v, of the pickup area 210 and the vol-ume v3 of the read area 230.
In one embodiment, the thickness t, of the first capillary gap 280 is in the range of about 0.025 to about 0.030 inch. The thickness t2 of the second capillary gap 290 is in the range of about 0.015 to about 0.020 inch. The thickness t2 of the second 3 o capillary gap 290, however, is less than the thickness t, of the first capillary gap 280.
The thickness t3 of the third capillary gap 340 is in the range of about 0.008 to about 0.0012 inch. The thickness t3 of the third capillary gap 340 must remain less than the thicknesses t, and t2 of the first and second capillary gaps 280, 290.
The operation of the device will now be described. The user moves the pickup area 210 into contact with a drop of blood on the user's fingertip. The pickup area 210 then fills with blood from the user's fingertip. Once the pickup area 210 is full, the transfer area 220 begins to fill with the blood. As discussed above, once the trans-fer area 220 begins to fill with blood, the user may then remove the testing device 200 from the user's fingertip. Since the transfer area 220 does not begin to fill with blood until after the pickup area is filled, and the pickup area has a volume v, greater than l0 the requisite volume needed for an accurate reading, the user can be assured that enough blood has been drawn.
Once the blood has filled the transfer area 220, the blood then begins to fill the read area 230. After the read area 230 is filled with blood, the sensor then reads the resulting change and indicates the glucose concentration to the user.
Turning now to FIGS. 7 and 8, an alternate embodiment of the test device 200 will be described. FIG. 7 is a top view of the test device, and FIG. 8 is a perspective view of the test device of FIG. 7, cut along line 7-7. Features that are the same as the previous embodiment will be numbered the same in this embodiment. In this em-bodiment, the read area 230 includes a capillary gap 820 created by supports 830, a 2 o filter 810, and a reagent impregnated paper 840. The filter 830 and reagent impreg-nated paper 840 are below the capillary gap 820. In this configuration, the blood needs to pass through the filter 810 before the reagent reacts with the blood.
It is also important to have the blood sample spread uniformly across the surface of the filter 810 prior to penetrating the filter 810 and reaching the top surface of the reagent im-2 5 pregnated paper 840, penetrating the reagent impregnated paper 840 and reacting with the reagent.
The capillary gap 820 above the filter 810 is produced by supports in the test device 200 and is arranged in such a pattern to promote spreading across the top sur-face of the filter 810. Thus, a uniform color change can be created along the read sur-3 o face of the reagent impregnated paper 840, allowing for an accurate reading by a photometric test unit.
The capillary gap distance t4 is less than the thickness t2 of the capillary gap 290 of the transfer area 220. Thus, the flow of blood acts the same in this embodi-ment.
While the present invention has been described with reference to one or more particular embodiments, those skilled in the art will recognize that many changes may be made thereto without departing from the spirit and scope of the present invention.
Each of these embodiments and obvious variations thereof is contemplated as falling within the spirit and scope of the claimed invention, which is set forth in the following claims.
Claims (53)
1. A test device adapted to test a concentration of an analyte in a fluid compris-ing:
a pickup area having a first volume for receiving the fluid; and a read area in fluid communication with the pickup area and having a second volume less than the first volume, such that the read area is adapted to receive fluid from the pickup area only after the pickup area is full, the read area containing a reagent adapted to produce a reaction indicative of the concentration of the analyte in the fluid.
a pickup area having a first volume for receiving the fluid; and a read area in fluid communication with the pickup area and having a second volume less than the first volume, such that the read area is adapted to receive fluid from the pickup area only after the pickup area is full, the read area containing a reagent adapted to produce a reaction indicative of the concentration of the analyte in the fluid.
2. The test device according to claim 1, wherein the pickup area comprises a first sidewall and a second sidewall independent of a floor or a ceiling.
3. The test device according to claim 1, wherein the read area comprises a ceiling and a floor.
4. The test device according to claim 3, wherein the ceiling of the read area is a plastic film.
5. The test device according to claim 3, wherein the ceiling of the read area is a porous paper.
6. The test device according to claim 5, wherein the floor of the read area is a filter.
7. The test device according to claim 5, wherein the ceiling of the read area in-cludes at least one support, adapted to hold the ceiling a predetermined distance from the floor.
8. The test device according to claim 1, further comprising a transfer area in fluid communication with the read area and the pickup area, adapted to transfer the fluid from the pickup area into the read area.
9. The test device according to claim 8, wherein the transfer area has a third vol-ume which is less than the first volume of the pickup area and larger than the second volume of the read area.
10. The test device according to claim 9, wherein the transfer area has sidewalls which are thinner than a sidewall of the pickup area.
11. The test device according to claim 8, wherein each of the pickup area, the transfer area, and the read area have capillary gaps to draw the fluid into the pickup area, the transfer area, and the read area.
12. The test device according to claim 11, wherein the capillary gap of the pickup area is larger than the capillary gap of the transfer area.
13. The test device according to claim 11, wherein the capillary gap of the transfer area is larger than the capillary gap of the read area.
14. The test device according to claim 1, wherein the second volume is in the range of about 70 to about 80 percent as large as the first volume.
15. The test device according to claim 14, wherein the second volume is in the range of about 3.5 to about 4.0 microliters and the first volume is in the range of about 4.5 to about 5.5 microliters.
16. The test device according to claim 1, wherein the reagent is adapted to produce a colorimetric reaction.
17. The test device according to claim 16, in combination with a colorimetric sen-sor.
18. The test device according to claim 1, wherein the reagent is adapted to produce an electrochemical reaction.
19. The test device according to claim 18, in combination with an electrochemical sensor.
20. The test device according to claim 1, wherein the analyte is g~~~.
21. The test device according to claim 20, in combination with a sensor adapted to measure the concentration of glucose in blood.
22. A test device adapted to test a concentration of an analyte in a fluid, compris-ing:
a pickup area having a first capillary gap adapted to use capillary action to draw the fluid into the pickup area; and a read area in fluid communication with the pickup area and having a second capillary gap which is smaller than the first capillary gap of the pickup area, such that the fluid is drawn into the second capillary gap of the read area only after the first capillary gap of the pickup area is entirely filled.
a pickup area having a first capillary gap adapted to use capillary action to draw the fluid into the pickup area; and a read area in fluid communication with the pickup area and having a second capillary gap which is smaller than the first capillary gap of the pickup area, such that the fluid is drawn into the second capillary gap of the read area only after the first capillary gap of the pickup area is entirely filled.
23. The test device according to claim 22, wherein the pickup area comprises a first sidewall and a second sidewall independent of a floor or a ceiling.
24. The test device according to claim 22, wherein the pickup area has a first vol-ume and the read area has a second volume, such that the first volume of the pickup area is greater than the second volume of the read area.
25. The test device according to claim 24, wherein the read area volume is from about 70 to about 80 percent as large as the pickup area volume.
26. The test device according to claim 24, wherein the read area volume is from about 3.5 to about 4.0 microliters and the pickup area volume is from about 4.5 to about 5.5 microliters.
27. The test device according to claim 22, further comprising a transfer area in fluid communication with the read area and the pickup area, adapted to transfer the analyte from the pickup area into the read area.
28. The test device according to claim 27, wherein the pickup area has a first vol-ume, the read area has a second volume, and a transfer area has a third volume, the third volume being less than the first volume of the pickup area and larger than the second volume of the read area.
29. The test device according to claim 22, wherein the read area comprises a top and a bottom independent of any sidewalls.
30. The test device according to claim 29, wherein the bottom of the read area is a porous paper.
31. The test device according to claim 30, wherein the top of the read area is a fil-ter.
32. The test device according to claim 5, wherein the ceiling of the read area in-cludes at least one support, adapted to hold the ceiling a predetermined distance from the floor.
33. The test device according to claim 22, wherein the reagent is adapted to pro-duce a colorimetric reaction.
34. The test device according to claim 33, in combination with a colorimetric sen-sor.
35. The test device according to claim 22, wherein the reagent is adapted to pro-duce an electrochemical reaction.
36. The test device according to claim 35, in combination with an electrochemical sensor.
37. The test device according to claim 22, wherein the analyte is glucose.
38. The test device according to claim 37, in combination with a sensor adapted to measure the concentration of glucose in a substance.
39. A blood chemical monitoring system for monitoring the concentration of an analyte in a fluid, comprising:
a pickup nib having a capillary gap adapted to use capillary action to draw the fluid into the pickup area, wherein the pickup nib further comprises a first sidewall and a second sidewall independent of a top side and a bottom side;
a read island adapted to draw the fluid from the pickup nib and having a cap-illary gap which is smaller than the capillary gap of the pickup area, such that the fluid is drawn into the capillary gap of the read area after the capillary gap of the pickup nib is entirely filled, wherein the read island further comprises a floor and a ceiling independent of any side-walls, so as to prevent the formation of air gaps; and a sensor for determining the concentration of the analyte in the fluid.
a pickup nib having a capillary gap adapted to use capillary action to draw the fluid into the pickup area, wherein the pickup nib further comprises a first sidewall and a second sidewall independent of a top side and a bottom side;
a read island adapted to draw the fluid from the pickup nib and having a cap-illary gap which is smaller than the capillary gap of the pickup area, such that the fluid is drawn into the capillary gap of the read area after the capillary gap of the pickup nib is entirely filled, wherein the read island further comprises a floor and a ceiling independent of any side-walls, so as to prevent the formation of air gaps; and a sensor for determining the concentration of the analyte in the fluid.
40. A method for determining a concentration of an analyte in a fluid with a test device, the test device comprising a pickup area and a read area in fluid communica-tion with the pickup area, the method comprising:
drawing the fluid into the pickup area;
filling the pickup area with the fluid; and drawing the fluid into the read area after the pickup area is substantially full of the fluid.
drawing the fluid into the pickup area;
filling the pickup area with the fluid; and drawing the fluid into the read area after the pickup area is substantially full of the fluid.
41. The method according to claim 40, further comprising mixing the fluid in the read area with a reagent disposed in the read area to produce a reaction.
42.The method according to claim 41, wherein the reaction is a colorimetric reac-tion.
43. The method according to claim 40, further comprising producing a signal in-dicative of the concentration of the analyte in the fluid.
44. The method according to claim 43, wherein the signal is a change in color.
45. The method according to claim 40, further comprising drawing the fluid into a transfer area after filling the fluid into the pickup area and prior to drawing the fluid into the read area.
46. The method according to claim 45, further comprising filling the transfer area with fluid prior to drawing the fluid into the read area.
47. The method according to claim 46, wherein filling the transfer area with fluid comprises using capillary action.
48. The method according to claim 40, wherein filling the read area with fluid comprises using capillary action.
49. The method according to claim 40, wherein filling the pickup area with the fluid comprises using capillary action.
50. The method according to claim 40, further comprising retaining fluid in the read area such that the likelihood of contamination of read instruments is reduced.
51. The method according to claim 40, wherein the analyte is glucose and the fluid is blood.
52. The method according to claim 40, further comprising using a sensor to read the concentration of the analyte in the fluid.
53. A test device adapted to test a concentration of an analyte in a fluid, compris-ing:
a pickup area having a first volume for receiving the fluid and a first capillary gap adapted to use capillary action to draw the fluid into the pickup area; and a read area in fluid communication with the pickup area and having a second volume less than the first volume, such that the read area is adapted to receive fluid from the pickup area only after the pickup area is full, the read area further having a second capillary gap which is smaller than the first capillary gap, such that the fluid is drawn into the second cap-illary gap after the first capillary gap is entirely filled, the read area containing a reagent adapted to produce a reaction indicative of the concentration of the analyte in the fluid.
a pickup area having a first volume for receiving the fluid and a first capillary gap adapted to use capillary action to draw the fluid into the pickup area; and a read area in fluid communication with the pickup area and having a second volume less than the first volume, such that the read area is adapted to receive fluid from the pickup area only after the pickup area is full, the read area further having a second capillary gap which is smaller than the first capillary gap, such that the fluid is drawn into the second cap-illary gap after the first capillary gap is entirely filled, the read area containing a reagent adapted to produce a reaction indicative of the concentration of the analyte in the fluid.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30355001P | 2001-07-09 | 2001-07-09 | |
US60/303,550 | 2001-07-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2392154A1 true CA2392154A1 (en) | 2003-01-09 |
Family
ID=23172619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002392154A Abandoned CA2392154A1 (en) | 2001-07-09 | 2002-06-28 | Volume meter testing device |
Country Status (9)
Country | Link |
---|---|
US (1) | US7776608B2 (en) |
EP (1) | EP1275963B1 (en) |
JP (1) | JP3863075B2 (en) |
AT (1) | ATE439586T1 (en) |
AU (1) | AU785113B2 (en) |
CA (1) | CA2392154A1 (en) |
DE (1) | DE60233296D1 (en) |
DK (1) | DK1275963T3 (en) |
ES (1) | ES2329765T3 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776608B2 (en) | 2001-07-09 | 2010-08-17 | Bayer Healthcare Llc | Volume meter testing device and method of use |
US7604775B2 (en) * | 2002-08-12 | 2009-10-20 | Bayer Healthcare Llc | Fluid collecting and monitoring device |
US8153081B2 (en) * | 2003-05-29 | 2012-04-10 | Bayer Healthcare Llc | Test sensor and method for manufacturing the same |
WO2007133456A2 (en) * | 2006-05-08 | 2007-11-22 | Bayer Healthcare Llc | Test sensor with under-fill protection |
DE102006025477B4 (en) * | 2006-05-30 | 2009-01-15 | Ekf - Diagnostic Gmbh | Cuvette and process for its preparation |
DE102006038271A1 (en) * | 2006-08-11 | 2008-02-14 | Senslab-Gesellschaft Zur Entwicklung Und Herstellung Bioelektrochemischer Sensoren Mbh | Sensor device useful in clinical diagnostics for the continuous and semi-continuous measurement of substances in blood or interstitial liquid, comprises polycarbonate foil with flow cell arranged parallelly to planar structured sensor |
JP4811267B2 (en) * | 2006-12-22 | 2011-11-09 | パナソニック株式会社 | Microchip and analytical device using the same |
GB0918462D0 (en) * | 2009-10-21 | 2009-12-09 | Spd Swiss Prec Diagnostics Gmb | Connection assembly and method |
AU2013293078B2 (en) * | 2012-07-23 | 2017-09-07 | Tasso, Inc. | Methods, systems, and devices relating to open microfluidic channels |
US20140116893A1 (en) * | 2012-10-29 | 2014-05-01 | Lifescan, Inc. | System and method for reduction of perceived inaccuracy of analyte measurements |
EP2778679B1 (en) | 2013-03-15 | 2017-09-27 | Ortho-Clinical Diagnostics, Inc. | Rotable disk-shaped fluid sample collection device |
CN107238573A (en) * | 2016-03-29 | 2017-10-10 | 光宝电子(广州)有限公司 | Fluid detecting device |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE399768B (en) | 1975-09-29 | 1978-02-27 | Lilja Jan E | CYVETT FOR SAMPLING, MIXING OF, THE SAMPLE WITH A REAGENTS AND DIRECT PERFORMANCE OF, SPECIAL OPTICAL, ANALYSIS OF THE SAMPLE MIXED WITH THE REAGENTS |
US4426451A (en) | 1981-01-28 | 1984-01-17 | Eastman Kodak Company | Multi-zoned reaction vessel having pressure-actuatable control means between zones |
US4756884A (en) | 1985-08-05 | 1988-07-12 | Biotrack, Inc. | Capillary flow device |
US5004923A (en) | 1985-08-05 | 1991-04-02 | Biotrack, Inc. | Capillary flow device |
US4761381A (en) * | 1985-09-18 | 1988-08-02 | Miles Inc. | Volume metering capillary gap device for applying a liquid sample onto a reactive surface |
US4935346A (en) | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
US5049487A (en) | 1986-08-13 | 1991-09-17 | Lifescan, Inc. | Automated initiation of timing of reflectance readings |
DE3630999A1 (en) | 1986-09-12 | 1988-03-17 | Boehringer Mannheim Gmbh | MULTI-LAYER TEST CARRIER |
US4753776A (en) | 1986-10-29 | 1988-06-28 | Biotrack, Inc. | Blood separation device comprising a filter and a capillary flow pathway exiting the filter |
US4895798A (en) | 1987-11-13 | 1990-01-23 | Miles, Inc. | Test devices for determination of occult blood |
US5039617A (en) | 1989-04-20 | 1991-08-13 | Biotrack, Inc. | Capillary flow device and method for measuring activated partial thromboplastin time |
US5286454A (en) | 1989-04-26 | 1994-02-15 | Nilsson Sven Erik | Cuvette |
US5472671A (en) * | 1989-04-26 | 1995-12-05 | Nilsson; Sven-Erik | Cuvette |
US6395227B1 (en) | 1989-08-28 | 2002-05-28 | Lifescan, Inc. | Test strip for measuring analyte concentration over a broad range of sample volume |
DE69023476T2 (en) | 1990-02-22 | 1996-03-21 | Editek Inc | Multi-layer test device for the determination of substances in liquids. |
US6156270A (en) * | 1992-05-21 | 2000-12-05 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
US5843691A (en) | 1993-05-15 | 1998-12-01 | Lifescan, Inc. | Visually-readable reagent test strip |
DE4326339A1 (en) | 1993-08-05 | 1995-02-09 | Boehringer Mannheim Gmbh | System for analysis of sample liquids |
US5770389A (en) | 1993-09-27 | 1998-06-23 | Abbott Laboratories | Apparatus and method for determining the quanity of an analyte in a biological sample by means of transmission photometry |
US5700695A (en) | 1994-06-30 | 1997-12-23 | Zia Yassinzadeh | Sample collection and manipulation method |
US5585069A (en) | 1994-11-10 | 1996-12-17 | David Sarnoff Research Center, Inc. | Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis |
JPH08145980A (en) | 1994-11-25 | 1996-06-07 | Otax Kk | Chip for inspecting water-based liquid |
DE19523049A1 (en) | 1995-06-24 | 1997-01-02 | Boehringer Mannheim Gmbh | Multilayer analysis element for the determination of an analyte in a liquid |
US5611999A (en) | 1995-09-05 | 1997-03-18 | Bayer Corporation | Diffused light reflectance readhead |
US6299838B1 (en) | 1995-10-06 | 2001-10-09 | Kyoto Daiichi Kagaku Co., Ltd. | Test apparatus for assaying a component in a liquid sample |
JPH09133673A (en) | 1995-11-10 | 1997-05-20 | Kdk Corp | Instrument and method for measuring liquid sample |
US5723284A (en) | 1996-04-01 | 1998-03-03 | Bayer Corporation | Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood |
US5962215A (en) | 1996-04-05 | 1999-10-05 | Mercury Diagnostics, Inc. | Methods for testing the concentration of an analyte in a body fluid |
DE19629656A1 (en) | 1996-07-23 | 1998-01-29 | Boehringer Mannheim Gmbh | Diagnostic test carrier with multilayer test field and method for the determination of analyte with its aid |
US6027459A (en) | 1996-12-06 | 2000-02-22 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US5759364A (en) | 1997-05-02 | 1998-06-02 | Bayer Corporation | Electrochemical biosensor |
US6300138B1 (en) * | 1997-08-01 | 2001-10-09 | Qualigen, Inc. | Methods for conducting tests |
DE19753847A1 (en) | 1997-12-04 | 1999-06-10 | Roche Diagnostics Gmbh | Analytical test element with capillary channel |
DE19815684A1 (en) | 1998-04-08 | 1999-10-14 | Roche Diagnostics Gmbh | Process for the preparation of analytical aids |
US6521182B1 (en) | 1998-07-20 | 2003-02-18 | Lifescan, Inc. | Fluidic device for medical diagnostics |
US6162397A (en) | 1998-08-13 | 2000-12-19 | Lifescan, Inc. | Visual blood glucose test strip |
US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6368563B1 (en) * | 1999-03-12 | 2002-04-09 | Integ, Inc. | Collection well for body fluid tester |
DE60025751T2 (en) | 1999-11-15 | 2006-10-12 | Arkray, Inc. | BIOSENSOR |
US6403037B1 (en) * | 2000-02-04 | 2002-06-11 | Cepheid | Reaction vessel and temperature control system |
DE10008906A1 (en) | 2000-02-25 | 2001-08-30 | Bayer Ag | Test system based on microcapillaries |
US6612111B1 (en) | 2000-03-27 | 2003-09-02 | Lifescan, Inc. | Method and device for sampling and analyzing interstitial fluid and whole blood samples |
US6814843B1 (en) | 2000-11-01 | 2004-11-09 | Roche Diagnostics Corporation | Biosensor |
US7776608B2 (en) | 2001-07-09 | 2010-08-17 | Bayer Healthcare Llc | Volume meter testing device and method of use |
DE10140680A1 (en) | 2001-08-24 | 2003-03-06 | Bayer Ag | Spectroscopic test system based on microcapillaries |
US6949297B2 (en) | 2001-11-02 | 2005-09-27 | 3M Innovative Properties Company | Hybrid adhesives, articles, and methods |
US6723500B2 (en) | 2001-12-05 | 2004-04-20 | Lifescan, Inc. | Test strips having reaction zones and channels defined by a thermally transferred hydrophobic barrier |
US20030171696A1 (en) | 2002-03-05 | 2003-09-11 | Bayer Healthcare, Llc | Minimum invasive optical format with integrated lance |
US20030143113A2 (en) | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
US7604775B2 (en) | 2002-08-12 | 2009-10-20 | Bayer Healthcare Llc | Fluid collecting and monitoring device |
WO2005077274A1 (en) | 2004-02-06 | 2005-08-25 | Bayer Healthcare Llc | Method and apparatus for measuring an analyte in a body fluid |
CA2566432A1 (en) | 2004-05-14 | 2005-12-01 | Steven C. Charlton | Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same |
RU2400733C2 (en) | 2004-12-13 | 2010-09-27 | Байер Хелткэр Ллк | Transmission spectroscopy system for use in determining analysed substances in body fluids |
-
2002
- 2002-06-20 US US10/174,833 patent/US7776608B2/en not_active Expired - Fee Related
- 2002-06-26 ES ES02013986T patent/ES2329765T3/en not_active Expired - Lifetime
- 2002-06-26 AT AT02013986T patent/ATE439586T1/en not_active IP Right Cessation
- 2002-06-26 EP EP02013986A patent/EP1275963B1/en not_active Expired - Lifetime
- 2002-06-26 DE DE60233296T patent/DE60233296D1/en not_active Expired - Lifetime
- 2002-06-26 DK DK02013986T patent/DK1275963T3/en active
- 2002-06-28 CA CA002392154A patent/CA2392154A1/en not_active Abandoned
- 2002-07-01 AU AU52747/02A patent/AU785113B2/en not_active Ceased
- 2002-07-05 JP JP2002197563A patent/JP3863075B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60233296D1 (en) | 2009-09-24 |
AU5274702A (en) | 2003-01-16 |
EP1275963B1 (en) | 2009-08-12 |
ES2329765T3 (en) | 2009-12-01 |
US20030007893A1 (en) | 2003-01-09 |
JP2003107098A (en) | 2003-04-09 |
US7776608B2 (en) | 2010-08-17 |
ATE439586T1 (en) | 2009-08-15 |
EP1275963A2 (en) | 2003-01-15 |
EP1275963A3 (en) | 2004-11-17 |
JP3863075B2 (en) | 2006-12-27 |
DK1275963T3 (en) | 2009-11-16 |
AU785113B2 (en) | 2006-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6960287B2 (en) | Underfill detection system for a test sensor | |
EP2277442B1 (en) | Fluid collection apparatus having an integrated lancet and reaction area | |
CA2350307C (en) | Hollow microneedle patch | |
AU2003204930B2 (en) | Sensor with Integrated Lancet | |
KR101386992B1 (en) | Method for determination of analyte concentrations and related apparatus | |
JP5736355B2 (en) | Electrochemical sensor and method for determining the concentration of an analyte in a sample | |
US20040248312A1 (en) | Sensor with integrated lancet | |
WO2004005919A1 (en) | Device for quantitative analysis of biological materials | |
US9448197B2 (en) | Marker for readings taken from alternative site tests | |
US7776608B2 (en) | Volume meter testing device and method of use | |
EP3665479B1 (en) | Apparatus for accurate sensing of physiological substance in blood | |
WO1999035487A1 (en) | Methods and apparatus for accurate analysis of bodily fluid constituents | |
JP2009536733A (en) | Test sensor with prevention of underfilling |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20110117 |